These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7214016

  • 1. Enhancement of iron chelation by desferrioxamine entrapped in red blood cell ghosts.
    Green R, Miller J, Crosby W.
    Blood; 1981 May; 57(5):866-72. PubMed ID: 7214016
    [Abstract] [Full Text] [Related]

  • 2. Clinical trial of desferrioxamine entrapped in red cell ghosts.
    Green R, Lamon J, Curran D.
    Lancet; 1980 Aug 16; 2(8190):327-30. PubMed ID: 6105474
    [Abstract] [Full Text] [Related]

  • 3. Determinants of fecal and urinary iron excretion in desferrioxamine-treated rats.
    Hershko C.
    Blood; 1978 Mar 16; 51(3):415-23. PubMed ID: 623907
    [Abstract] [Full Text] [Related]

  • 4. Red cell ghost-entrapped deferoxamine as a model clinical targeted delivery system for iron chelators and other compounds.
    Green R.
    Bibl Haematol; 1985 Mar 16; (51):25-35. PubMed ID: 4004761
    [Abstract] [Full Text] [Related]

  • 5. IRC011, a new synthetic chelator with selective interaction with catabolic red blood cell iron: evaluation in hypertransfused rats with hepatocellular and reticuloendothelial radioiron probes and in iron-loaded rat heart cells in culture.
    Rivkin G, Link G, Simhon E, Cyjon RL, Klein JY, Hershko C.
    Blood; 1997 Nov 15; 90(10):4180-7. PubMed ID: 9354689
    [Abstract] [Full Text] [Related]

  • 6. ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture.
    Hershko C, Konijn AM, Nick HP, Breuer W, Cabantchik ZI, Link G.
    Blood; 2001 Feb 15; 97(4):1115-22. PubMed ID: 11159545
    [Abstract] [Full Text] [Related]

  • 7. Storage iron kinetics. 3. Study of desferrioxamine action by selective radioiron labels of RE and parenchymal cells.
    Hershko C, Cook JD, Finch DA.
    J Lab Clin Med; 1973 Jun 15; 81(6):876-86. PubMed ID: 4196982
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mobilisation of iron from peritoneal rat macrophages by desferrioxamine.
    Kleber EE, Torrance JD, Bothwell TH, Simon MO, Charlton RW.
    Scand J Haematol; 1981 Sep 15; 27(3):209-18. PubMed ID: 7313547
    [Abstract] [Full Text] [Related]

  • 10. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
    Zevin S, Link G, Grady RW, Hider RC, Peter HH, Hershko C.
    Blood; 1992 Jan 01; 79(1):248-53. PubMed ID: 1728313
    [Abstract] [Full Text] [Related]

  • 11. A study of the mechanisms and sites of action of desferrioxamine in thalassaemia major.
    Bianco I, Graziani B, Lerone M, Congedo P, Clemente GF, Ingrao G, Ciccone F, Di Nucci GD, Mandelli F, Isacchi G.
    Acta Haematol; 1984 Jan 01; 71(2):100-5. PubMed ID: 6421046
    [Abstract] [Full Text] [Related]

  • 12. Storage iron exchange in the rat as affected by deferoxamine.
    Kim BK, Huebers H, Pippard MJ, Finch CA.
    J Lab Clin Med; 1985 Apr 01; 105(4):440-8. PubMed ID: 3920336
    [Abstract] [Full Text] [Related]

  • 13. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ, Sheppard L, Hoffbrand AV, Charalambous J, Tikerpae J, Pippard MJ.
    J Clin Pathol; 1987 Apr 01; 40(4):404-8. PubMed ID: 3584483
    [Abstract] [Full Text] [Related]

  • 14. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Roberts DJ, Rees D, Howard J, Hyde C, Alderson P, Brunskill S.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD004450. PubMed ID: 16235363
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chelation of transferrin iron by desferrioxamine in K562 cells. The partition of iron between ferrioxamine and ferritin.
    Roberts S, Bomford A.
    Biochem J; 1988 Sep 15; 254(3):869-75. PubMed ID: 3196300
    [Abstract] [Full Text] [Related]

  • 17. Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload.
    Hussain MA, Green N, Flynn DM, Hussein S, Hoffbrand AV.
    Lancet; 1976 Dec 11; 2(7998):1278-80. PubMed ID: 63749
    [Abstract] [Full Text] [Related]

  • 18. Iron chelation in red cell ghosts.
    Smith GN.
    Lancet; 1976 Dec 11; 2(8208-8209):1363. PubMed ID: 6109171
    [No Abstract] [Full Text] [Related]

  • 19. Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects.
    Summers MR, Jacobs A, Tudway D, Perera P, Ricketts C.
    Br J Haematol; 1979 Aug 11; 42(4):547-55. PubMed ID: 476006
    [Abstract] [Full Text] [Related]

  • 20. Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias.
    Pippard MJ, Callender ST, Weatherall DJ.
    Clin Sci Mol Med; 1978 Jan 11; 54(1):99-106. PubMed ID: 620500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.